ALLMedicine™ Acute Myeloblastic Leukemia Center
Research & Reviews 26 results
https://doi.org/10.1016/j.leukres.2021.106751
Leukemia Research; Mirfakhraie R, Noorazar L et. al.
Nov 23rd, 2021 - Acute myeloblastic leukemia (AML) is one of the most common types of blood malignancies that results in an AML-associated high mortality rate each year. Several causes have been reported as prognostic factors for AML in children and adults, the mo...
https://doi.org/10.3324/haematol.2021.279010
Haematologica Russell NH, Hills RK et. al.
Oct 15th, 2021 - Reduced Intensity Conditioning (RIC) transplantation is increasingly offered to older patients with acute myeloblastic leukemia (AML). We have previously shown that a RIC allograft, particularly from a sibling donor is beneficial in intermediate r...
https://doi.org/10.1080/17474086.2021.1969911
Expert Review of Hematology; Cerchione C, Peleteiro Raíndo A et. al.
Aug 24th, 2021 - Introduction: Acute myeloblastic leukemia (AML) is the most frequent type of acute leukemia in adults with an incidence of 4.2 cases per 100,000 inhabitants and poor 5-year survival. Patients with mutations in the FMS-like tyrosine kinase 3 (FLT3)...
https://doi.org/10.1097/MPH.0000000000002225
Journal of Pediatric Hematology/oncology; Aylan Gelen S, Sarper N et. al.
Jun 1st, 2021 - Indications of leukapheresis (LPh) and the prophylactic use of rasburicase in tumor lysis syndrome (TLS) of patients with acute leukemia with hyperleukocytosis are not clear. In this retrospective single-center pediatric study, the outcomes of pat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137019
Medicine Matei E, Aschie M et. al.
May 21st, 2021 - At present, various researches presented how subtypes of hematological malignancies are related to stages of the immune response, because the activated immune system represents a promising form in cancer treatment. This study explores the relation...
